Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 15, 2025 16:05 ET | Source: Adaptive Biotechnologies

Adaptive Biotechnologies to Report Third Quarter 2025 Financial Results on November 5, 2025

SEATTLE, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune...
August 27, 2025 16:05 ET | Source: Adaptive Biotechnologies

Adaptive Biotechnologies to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

SEATTLE, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune...
August 05, 2025 16:05 ET | Source: Adaptive Biotechnologies

Adaptive Biotechnologies Reports Second Quarter 2025 Financial Results

SEATTLE, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the...
July 15, 2025 16:05 ET | Source: Adaptive Biotechnologies

Adaptive Biotechnologies to Report Second Quarter 2025 Financial Results on August 5, 2025

SEATTLE, July 15, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune...
July 01, 2025 07:30 ET | Source: Adaptive Biotechnologies

Adaptive Biotechnologies and Flatiron Health Announce Integration of clonoSEQ® MRD Testing into OncoEMR®

clonoSEQ® is now integrated into Flatiron Health’s OncoEMR®, simplifying MRD testing access for over 4,500 clinicians across the Flatiron network.
May 30, 2025 07:30 ET | Source: Adaptive Biotechnologies

Adaptive Biotechnologies Highlights New Data at 2025 ASCO Annual Meeting and EHA 2025 Congress Demonstrating How clonoSEQ® MRD Assessment is Optimizing Patient Care and Drug Development in Lymphoid Cancers

SEATTLE, May 30, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune...
May 28, 2025 16:05 ET | Source: Adaptive Biotechnologies

Adaptive Biotechnologies to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

SEATTLE, May 28, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune...
May 01, 2025 16:05 ET | Source: Adaptive Biotechnologies

Adaptive Biotechnologies Reports First Quarter 2025 Financial Results

SEATTLE, May 01, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the...
April 10, 2025 16:05 ET | Source: Adaptive Biotechnologies

Adaptive Biotechnologies to Report First Quarter 2025 Financial Results on May 1, 2025

SEATTLE, April 10, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune...
April 08, 2025 08:00 ET | Source: Adaptive Biotechnologies

Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Surveillance in Mantle Cell Lymphoma

SEATTLE, April 08, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune...